New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 4932 | RuBi-Dopa | Caged dopamine; exhibits two-photon sensitivity |
| 4921 | Leukadherin 1 | Allosteric activator of CD11b/CD18 |
| 4918 | GSA 10 | Smo receptor agonist |
| 4914 | Phrixotoxin 3 | Potent modulator of NaV1.2, NaV1.3 and NaV1.5 channels |
| 4887 | OAC-1 | Oct4 activator; enhances iPSC reprogramming efficiency |
| 4844 | HJC 0350 | Selective Epac2 inhibitor |
| 4816 | Pentoxyresorufin | Fluorometric cytochrome P450 substrate |
| 4814 | Methoxyresorufin | Fluorometric CYP450 substrate |
| 4801 | QNZ 46 | NR2C/NR2D-selective NMDA receptor non-competitive antagonist |
| 4527 | TC-I 15 | Potent α2β1 inhibitor; displays antithrombotic activity in vivo |
| 3412 | (Z)-4-Hydroxytamoxifen | Metabolite of tamoxifen (Cat. No. 0999) |
| 3220 | ShK-Dap22 | Extremely potent and selective KV1.3 blocker; suppresses T cell activation in vitro |
| 2983 | GM 6001 | Broad-spectrum MMP inhibitor |